False World Vs. Real World: A Strong Argument for RWD

Lucy Brake speaks to Mike Rea, CEO of IDEA Pharma, about how he believes real world evidence impacts current development and trials processes, and the ways in which pharma can take best take advantage of all this offers. Read entire article here. (Source: eyeforpharma, May 16, 2013)

You might also be interested in:

Eyeforpharma Webinar to Spotlight Blockchain June 25, 2018
Article: Rise of Digital Health Data Bolsters Interest in RWD August 18, 2018
ICER Publishes Guidance on Improving Development, Use of RWE… April 11, 2018
Q&A With Lou Garrison on RWE, HTA April 21, 2018
HealthCare Partners Holding OKs $270M Settlement Over False… October 3, 2018
Outcomes-Based Contracts: Much hype, Far Less Practice? June 23, 2018
How Will the FDA’s Payer Communications Guidance Affect… July 18, 2018